CD34

CD34 분자 정보

영어 이름Hematopoietic progenitor cell antigen CD34시판 약물 수1
임상 약물 수12표적 별명CD34,CD34 Molecule,CD34 Antigen,Hematopoietic Progenitor Cell Antigen CD34,Antigens, CD34
최고 연구 개발 단계Approved
영어 이름Hematopoietic progenitor cell antigen CD34
표적 별명CD34,CD34 Molecule,CD34 Antigen,Hematopoietic Progenitor Cell Antigen CD34,Antigens, CD34
시판 약물 수1
임상 약물 수12
최고 연구 개발 단계Approved

CD34 제품 목록

  • 속성

    Protein (3)Antibody (1)

  • 제품 라이브러리

    온라인 (4)

  • Human (3)Mouse (1)

  • 태그

    His Tag (2)His Tag & Avi Tag (1)- (1)

  • 마커

    Unconjugated (1)Biotin-labeled (1)PE Labeled (2)

CD34분자 배경

CD34 molecule is a cluster of differentiation molecule present on certain cells within the human body. It is a cell surface glycoprotein and functions as a cell-cell adhesion factor. It may also mediate the attachment of stem cells to bone marrow extracellular matrix or directly to stromal cells. As a ~ 110 kDa monomeric cell surface antigen, CD34 is highly glycosylated with nine potential N-linked and numerous potential O-linked glycosylation sites in its extracellular domain. The CD34 protein is a member of a family of single-pass transmembrane sialomucin proteins that show expression on early hematopoietic and vascular-associated tissue. CD34 is also an important adhesion molecule and is required for T cells to enter lymph nodes. It is expressed on lymph node endothelia whereas the L-selectin to which it binds is on the T cell. It was indicated that CD34 is a phosphorylation target for activated PKC, and couples to the hematopoietic adapter protein CrkL, which were involved in CD34 signaling pathways. CD34 is abberantly expressed in many kinds of tumors and is implicated in leukemogenesis.

CD34분자 별명

CD34,RP11-328D5.2

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
CLBS-12CLBS-12Phase 2 ClinicalCaladrius Biosciences IncAtherosclerosis; Ischemia; Thromboangiitis Obliterans
상세
Retroviral ADA-transduced CD34+ cells (NHGRI/UCLA)Phase 2 ClinicalUcla Biomedical LibraryAdenosine deaminase deficiency
상세
CD34+ bone marrow stem cells (University of California)Phase 2 ClinicalThe University Of California DavisDiabetic Retinopathy; Macular Degeneration; Retinal Vein Occlusion; Retinitis Pigmentosa
상세
Autologous peripheral blood stem cell therapy (CellProthera)Phase 2 ClinicalCellprotheraMyocardial Infarction
상세
CD34 stem cell therapy (LA Childrens Hospital)Phase 2 ClinicalChildren'S Hospital Of Los AngelesHeart Failure; HIV Infections
상세
Stem cell therapeutics (ExCellThera)ECT-002; ECT-003; ECT-005; UM171 + UM092; UM171 + UM390Phase 2 ClinicalExcellthera IncLeukemia, Myeloid, Acute
상세
Lentiviral vector transduced CD34+ cells TherapyPhase 2 ClinicalGreat Ormond Street Hospital For Children Nhs Foundation TrustGranulomatous Disease, Chronic
상세
Cord blood stem cells(Tatcitus Therapeutics/Mount Sinai Health System)HSC-100Phase 1 ClinicalIcahn School Of Medicine At Mount Sinai, Tatcitus TherapeuticsHematologic Neoplasms; Hodgkin Disease; Leukemia; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma
상세
shRNA-Modified CD34 Cell TherapyKL-AI20Phase 1 ClinicalKanglin Biotech (Hangzhou) Co LtdHIV Infections
상세
Alpha-galactosidase A stem cell therapy (University Health Network/Ozmosis)Phase 1 ClinicalUniversity Health Network (Uhn)Fabry Disease
상세
Autologous CD34+ Cells Therapy (Zhongji Zhiyao (Nanjing) Biotechnology Co Ltd)GMCN-508APhase 1 ClinicalZhongji Zhiyao (Nanjing) Biotechnology Co Ltdalpha-Thalassemia
상세
Donor-derived CD34+ HSC with CRISPR/Cas9-mediated CD33 deletion(German Cancer Research Center)Phase 1 ClinicalGerman Cancer Research Center (Dkfz)Leukemia, Myeloid, Acute
상세

시판 약물 정보

영어 이름연구 코드연구 개발 단계회사가장 빠른 브랜드 이름가장 빠른 승인 국가가장 빠른 적응증가장 빠른 승인 회사가장 빠른 승인 날짜적응증임상 시험
Anti-CD34 mab-sirolimus (OrbusNeich)ApprovedOrbusneichCoronary RestenosisOrbusneich2013-01-01Coronary Artery Disease; Coronary Restenosis
상세
  • 분자 정보
  • 제품 목록
  • 시판 약물 정보
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호